Signature Cross-Insurance Cost Matrix • Specialty / DME (00074301228)Continuous 16-Hour Jejunal Enteral Dopamine Infusion (Medicare Part B DME Benefit)

Duopa (Carbidopa / Levodopa Enteral Suspension — PEG-J Pump, HCPCS J7340): Cost Across Insurances

Complete cell-by-cell comparison across Self-Pay Cash, Original Medicare, 6 Major California Commercial Payers (Anthem, Blue Shield, UnitedHealthcare, Aetna, Cigna, Kaiser Permanente), and Medi-Cal — with every cell labeled with its official data source and effective date.

1. Published Prices(Cash & Medicare)2. Plan-Adjusted(Payer MRF Rate)3. Verified Price(Real-Time 270/271 Check)

Accuracy Level — Tier 1 Published Prices: You are currently viewing general published hospital cash prices, Medicare baselines, and multi-payer ranges. Add your insurance card to unlock Tier 2 plan pricing and Tier 3 verified benefit checks.

Tier 1: General Published Rates Across 9 InsurancesEvery cell labeled with official Source + Date • “Not published” shown honestly where proprietary

Hospital procedure cells are extracted from 14 Bay Area hospital MRFs (45 CFR § 180.50, Oct 2026); medication cells use CMS NADAC (as of 2026-10-28) & CY 2026 Medicare Part D / Medi-Cal Rx rules.

Parkinson's Service / Medication
Self-Pay / Cash Price
Hospital MRF / Retail Cash
Medicare Rate
2026 CMS / NADAC / Part D
Anthem Blue Cross
MRF Negotiated / Formulary
Blue Shield of CA
MRF Negotiated / Formulary
UnitedHealthcare
MRF Negotiated / Formulary
Aetna
MRF Negotiated / Formulary
Cigna
MRF Negotiated / Formulary
Kaiser Permanente
MRF Negotiated / Formulary
Medi-Cal (CA Medicaid)
CA DHCS / Medi-Cal Rx
MedicationSpecialty / DME (00074301228)
Duopa (Carbidopa / Levodopa Enteral Suspension — PEG-J Pump, HCPCS J7340)
$7,200 – $8,800 / 30 days (30 enteral cassettes + pump supplies)

$7,200 – $8,800 / 30 days (30 enteral cassettes + pump supplies)

Source: CMS Medicare Part B ASP Drug Pricing File (HCPCS J7340) & Specialty Infusion Benchmarks (Oct 2026)
Date: Oct 2026
Not published

Not published in CMS Retail NADAC (Dispensed as Medicare Part B DME Enteral Infusion Drug under HCPCS J7340) • Medicare Part D patient cost: Original Medicare + Medigap Plan G/N: $0 after $257 Part B deductible • Medicare Advantage / Original Medicare alone: 20% Part B coinsurance (up to Part C MOOP)

Source: CMS NADAC 2026 & CMS Medicare Part B ASP Pricing File (HCPCS J7340, Oct 2026) & CMS Medicare Benefit Policy Manual Ch. 15 §110 (DME External Infusion Pumps) & HCPCS J7340
Date: 2026-10-28
Not published

Medical/Specialty Pharmacy Benefit; Prior Authorization required (CG-DRUG-68). Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: Anthem Blue Cross 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
Not published

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: Blue Shield of CA 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
Not published

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: UnitedHealthcare 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
Not published

Medical/Specialty Benefit; Prior Authorization required (CPB 0017 / Specialty). Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: Aetna 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
Not published

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: Cigna 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
Not published

Requires movement-disorder subspecialist board review and authorization. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Source: Kaiser Permanente 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Date: Oct 2026
$0 patient copay

$0 copay with approved TAR / Medi-Cal Rx Prior Authorization.

Source: CA DHCS Medi-Cal Rx Contract Drug List (CDL) & PA Policy
Date: Oct 2026
Audit-Grade Cell Verification (9/9 Insurance Columns Sourced)

Every Insurance Cell for Duopa — With Source & Date Citations

Tier 1 Cash Baseline Published Rate

Self-Pay / Discounted Cash Price

$7,200 – $8,800 / 30 days (30 enteral cassettes + pump supplies)

$7,200 – $8,800 / 30 days (30 enteral cassettes + pump supplies)

Official Source: CMS Medicare Part B ASP Drug Pricing File (HCPCS J7340) & Specialty Infusion Benchmarks (Oct 2026)
Effective / Verified Date: Oct 2026
Federal Benchmark Not Published

Original Medicare (CMS 2026 / NADAC / Part D)

Not published in Retail NADAC

Not published in CMS Retail NADAC (Dispensed as Medicare Part B DME Enteral Infusion Drug under HCPCS J7340) • Medicare Part D patient cost: Original Medicare + Medigap Plan G/N: $0 after $257 Part B deductible • Medicare Advantage / Original Medicare alone: 20% Part B coinsurance (up to Part C MOOP)

Official Source: CMS NADAC 2026 & CMS Medicare Part B ASP Pricing File (HCPCS J7340, Oct 2026) & CMS Medicare Benefit Policy Manual Ch. 15 §110 (DME External Infusion Pumps) & HCPCS J7340
Effective / Verified Date: 2026-10-28
Commercial & MA MRF Not Published

Anthem Blue Cross (California)

Not published (PBM negotiated rate)

Medical/Specialty Pharmacy Benefit; Prior Authorization required (CG-DRUG-68). Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: Anthem Blue Cross 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
Commercial & MA MRF Not Published

Blue Shield of California

Not published (PBM negotiated rate)

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: Blue Shield of CA 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
Commercial & MA MRF Not Published

UnitedHealthcare (UHC)

Not published (PBM negotiated rate)

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: UnitedHealthcare 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
Commercial & MA MRF Not Published

Aetna

Not published (PBM negotiated rate)

Medical/Specialty Benefit; Prior Authorization required (CPB 0017 / Specialty). Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: Aetna 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
Commercial MRF Not Published

Cigna

Not published (PBM negotiated rate)

Medical/Specialty Benefit; Prior Authorization required. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: Cigna 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
Integrated HMO / MRF Not Published

Kaiser Permanente (Northern CA)

Not published (PBM negotiated rate)

Requires movement-disorder subspecialist board review and authorization. Commercial insurer-PBM net negotiated drug price is proprietary; CA SB 1021 caps state-regulated commercial copay at ≤ $250/30d if PA is approved.

Official Source: Kaiser Permanente 2026 CA Commercial Formulary & CA Health & Safety Code § 1367.241 (SB 1021)
Effective / Verified Date: Oct 2026
$0 Safety-Net Published Rate

Medi-Cal (California Medicaid / Medi-Cal Rx)

$0 patient copay

$0 copay with approved TAR / Medi-Cal Rx Prior Authorization.

Official Source: CA DHCS Medi-Cal Rx Contract Drug List (CDL) & PA Policy
Effective / Verified Date: Oct 2026
CMS NADAC & Medicare Part D Formulary Details

Duopa (Carbidopa / Levodopa Enteral Suspension — PEG-J Pump, HCPCS J7340) — Clinical & Formulary Summary

Open Full Medication Page

What it's for: Continuous 16-hour infusion of carbidopa/levodopa gel delivered directly into the small intestine (jejunum) via a portable CADD-Legacy pump and PEG-J tube to bypass erratic gastric emptying in advanced Parkinson's. (Source: FDA Prescribing Information (NDA 203952) & CMS Medicare Part B DMEPOS Policy)

CMS NADAC Baseline (2026-10-28)
Not published in CMS Retail NADAC (Dispensed as Medicare Part B DME Enteral Infusion Drug under HCPCS J7340)
30-Day Baseline: Not published in CMS Retail NADAC (Covered under Medicare Part B DMEPOS ASP + 6% fee schedule)
Source: CMS NADAC 2026 & CMS Medicare Part B ASP Pricing File (HCPCS J7340, Oct 2026)
2026 Medicare Part D Formulary Status
Tier: Covered under Medicare Part B DME (Durable Medical Equipment) — NOT Part D when infused via external CADD-Legacy pump
Prior Auth: Yes — requires documented severe motor fluctuations / OFF time despite optimized oral therapy AND PEG-J placement
2026 Patient Cost: Original Medicare + Medigap Plan G/N: $0 after $257 Part B deductible • Medicare Advantage / Original Medicare alone: 20% Part B coinsurance (up to Part C MOOP)